Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease and related acid‑related disorders. GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium, a proton pump inhibitor, is used to manage disorders associated with excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining a higher gastric pH. - Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions. - NSAID‑induced gastric ulcer: protects the gastric lining and supports ulcer resolution. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine condition.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, often transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps or irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Liver enzyme elevation: abnormal blood test results.

Before initiating therapy, consider the following safety measures. - Assess renal function: dose adjustment may be needed in severe impairment. - Review hepatic status: monitor liver enzymes in patients with liver disease. - Evaluate for osteoporosis risk: long‑term use may affect bone density. - Monitor for infection: proton pump inhibition can increase susceptibility to gastrointestinal infections. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Esomeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in anticoagulant effect. - Digoxin: possible rise in serum levels. - Methotrexate (high dose): decreased renal clearance may increase toxicity.